MetaCap

Grace Therapeutics Inc. Company Profile

NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.02-0.0755 (-3.60%)

Market open · Delayed 15 min · as of Oct 8, 2:36 PM ET

Grace Therapeutics at a glance

Grace Therapeutics Inc. (NASDAQ: GRCE) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Princeton, NJ, Canada. At a market capitalization of $43.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001444192, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

Company information

Legal name
Grace Therapeutics Inc.
Ticker
NASDAQ: GRCE
Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
103 Carnegie Center, Suite 300 08540, Princeton, NJ, Canada
Phone
609-322-1602
Market cap
$43.44M
SEC CIK
0001444192
Latest annual report
10-K · Jun 18, 2026

Companies similar to Grace Therapeutics

GRCE peer companies
CompanyPrice% ChgMarket capCompare
NSRXNasus Pharma Ltd.3.69-2.25%$43.22Mvs GRCE
SCYXSCYNEXIS Inc.4.28-10.46%$42.58Mvs GRCE
HOWLWerewolf Therapeutics Inc.0.92010.00%$44.72Mvs GRCE
CPHIChina Pharma Holdings Inc.0.96+13.09%$41.30Mvs GRCE
VERUVeru Inc.2.41-2.07%$41.07Mvs GRCE
IXHLIncannex Healthcare Inc.3.19+0.32%$40.02Mvs GRCE
CELUCelularity Inc. Class A1.47-0.34%$47.54Mvs GRCE
ELTXElicio Therapeutics Inc.1.81-2.16%$47.57Mvs GRCE

Related